Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad5-nCoV Vaccine in Adults Living with HIV
NCT05005156Phase 2Completed
- Sponsor
- Fundación Huésped
- Start
- Jun 2021
- Primary completion
- Jan 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ad5-ncov in coronavirus disease 2019 (COVID-19), sponsored by Fundación Huésped. Started Jun 2021; status: completed.
02
Drugs
ad5-ncov
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05005156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005156.